NCT05061732View on ClinicalTrials.gov

Helicobacter Pylori Eradication and Follow-up

PHASE4RecruitingINTERVENTIONAL

Enrollment

4,447

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Rabeprazole

20mg bid

DRUG

Bismuth potassium citrate

0.6g bid

DRUG

Metronidazole

0.4g qid

DRUG

Clarithromycin

0.5g bid

DRUG

Levofloxacin

0.5g qd

DRUG

Amoxicillin

1g tid

DRUG

Metronidazole

0.4g tid

DRUG

Doxycycline

0.1g bid

DRUG

Tetracycline

0.5g qid

Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors

lead

Shanghai Zhongshan Hospital

OTHER